Diagnostic options · UAE

Cancer Panels tests in Dubai & UAE

Compare available Cancer Panels tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

3,000.00–7,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Panels test prices

Showing 1–3 of 3 matching tests.

Cancer Panels diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1407 Lung Cancer Panel 7 (EGFR, BRAF, ALK1, ROS1, MET) Test This test evaluates key genetic mutations and rearrangements in EGFR, BRAF, ALK1, ROS1, and MET genes within a non-small cell lung cancer tumor sample.	Tumor tissue biopsy (formalin‑fixed paraffin‑embedded block or unstained slides)	5–7 business days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations (exon 19 deletions, L858R, T790M)", "BRAF V600E mutation", "ALK rearrangements", "ROS1 fusions", "MET amplification or exon 14 skipping mutations"] Parameters [] Preparation [] Indications ["Patients with confirmed or strongly suspected Non-Small Cell Lung Cancer (NSCLC)", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 92874-8 ICD-10: C34.90 Clinical summary This test evaluates key genetic mutations and rearrangements in EGFR, BRAF, ALK1, ROS1, and MET genes within a non-small cell lung cancer tumor sample.
TEST-2171 Myeloid Tumor Panel Genetic Test This test evaluates 37 genes associated with myeloid malignancies using Next-Generation Sequencing (NGS) to identify mutations relevant for diagnosis, prognosis, and treatment sele...	Peripheral Whole Blood (EDTA or FTA Card) or Bone Marrow Aspirate	21–28 Calendar Days (3–4 Weeks)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic and germline mutations", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [{"name": "Genes Analyzed", "reference_range": "37 Genes (ASXL1, TP53, FLT3, IDH1, IDH2, RUNX1, TET2, DNMT3A, SF3B1, SRSF2, U2AF1, CEBPA, NPM1, KIT, KRAS, NRAS, JAK2, CALR, MPL, EZH2, STAG2, BCOR, BCORL1, ZRSR2, RAD21, SMC1A, SMC3, PHF6, NF1, PTPN11, CBL, SETBP1, ETNK1, GATA2, WT1, IKZF1, MYD88)"}] Preparation ["No specific fasting required", "Inform lab if patient received blood transfusion within 48 hours"] Indications ["Diagnosis of AML, MDS, or MPN", "Prognosis assessment in myeloid malignancies", "Guidance for targeted therapy selection", "Minimal residual disease (MRD) monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 92833-1 ICD-10: C92.0 Clinical summary This test evaluates 37 genes associated with myeloid malignancies using Next-Generation Sequencing (NGS) to identify mutations relevant for diagnosis, prognosis, and treatment selection.
TEST-1266 Oncomine™ Lung cfTNA Cancer Panel (Liquid Biopsy) Test This test detects genetic alterations in cell-free tumor DNA from blood to guide lung cancer treatment.	10 mL peripheral blood (cfTNA)	14–21 business days	7,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants", "Insertions/deletions", "Copy-number changes", "Gene fusions", "Cell-free total nucleic acid (cfTNA)"] Parameters [] Preparation ["No fasting or special preparation is required"] Indications ["Patients with suspected or confirmed non-small cell lung cancer (NSCLC)", "Patients for whom tissue biopsy is medically risky", "Guiding first-line targeted therapy", "Tracking resistance mechanisms", "Serial disease surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 94574-2 ICD-10: C34.90 Clinical summary This test detects genetic alterations in cell-free tumor DNA from blood to guide lung cancer treatment.

Category overview

Cancer Panels: overview

When evaluating complex inherited cancer risks, a thorough and comprehensive approach brings profound reassurance and clear direction for your future care. Under our Molecular Diagnostics umbrella, our advanced Cancer Panels employ state-of-the-art sequencing to simultaneously evaluate multiple genetic markers associated with an increased risk of various malignancies. Instead of offering an absolute clinical diagnosis, the expansive data from these cancer panels equips your physician with the vital molecular insights needed for deeply tailored, preventive medical guidance. Trusted across the most respected diagnostic labs in Dubai and the UAE, DNA Labs UAE prioritizes rigorous patient confidentiality and consistently fast, accurate turnaround times. Secure your long-term health legacy today: explore our cancer panels testing in the UAE below to book your test, arrange a seamless home collection, or consult our specialized team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.